Medicare AI Prior Authorization Trial Cuts Medical Services Sharply

Medicare has begun testing artificial intelligence as a tool for conducting prior authorizations, a process typically used to curb unnecessary or wasteful medical spending, and the early results show a pronounced impact on the volume of care delivered to beneficiaries.

The pilot program represents a significant shift in how the federal health insurance program for seniors evaluates requests for medical services. Prior authorization has long been a mechanism insurers and government programs use to verify that proposed treatments meet coverage criteria before they are performed — a process critics argue can delay or deny necessary care.

Read more Class Politics Fractures Trump's Billionaire-Blue Collar Alliance →

The introduction of AI into that workflow accelerated decision-making, but the immediate consequence was a large drop in approved or pursued medical services, raising questions about whether the technology is filtering out genuinely wasteful procedures or creating new barriers to legitimate patient care. The distinction carries major implications for the roughly 65 million Americans enrolled in Medicare.

Proponents of AI-driven prior authorization argue the technology can more consistently apply coverage rules, reduce administrative burden, and flag billing irregularities faster than human reviewers. Opponents, including patient advocates and some physicians, warn that automated systems may lack the clinical nuance required to assess individual patient needs and could disproportionately affect vulnerable populations who depend on timely access to care.

The Medicare trial places the federal government at the center of a broader national debate over the role of algorithmic decision-making in healthcare, at a moment when AI adoption across the medical industry is accelerating rapidly. Continue reading at MarketWatch.com